Oct
24
LONDON AFP – Researchers at the University of Cambridge said Thursday they have found that a drug originally developed to treat leukaemia can halt and even reverse the debilitating effects of multiple sclerosis MS.
In trials, alemtuzumab reduced the number of attacks in sufferers and also helped them recover lost functions, apparently allowing damaged brain tissue to repair so that individuals were less disabled than at the start of the study.
“The ability of an MS drug to promote brain repair is unprecedented,” said Dr Alasdair Coles, a lecturer at Cambridge university’s department of clinical neurosciences, who coordinated many aspects of the study.
“We are witnessing a drug which, if given early enough, might effectively stop the advancement of the disease and also restore lost function by promoting repair of the damaged brain tissue.”
The MS Society, Britain’s largest support charity for those affected by the condition, said it was “delighted” at the trial’s results, which must be followed up with more research before the drug can be licensed.
“This is the first drug that has shown the potential to halt and even reverse the debilitating effects of MS and this news will rightly bring hope to people living with the condition day in, day out,” said head of research Lee Dunster.
Read the rest:Leukaemia drug can halt, reverse MS - Yahoo News
Comments
Leave a Reply